Literature DB >> 11435333

Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease.

H J Rupprecht1, S Blankenberg, C Bickel, G Rippin, G Hafner, W Prellwitz, W Schlumberger, J Meyer.   

Abstract

BACKGROUND: The number of infectious pathogens to which an individual has been exposed (infectious burden) may correlate with coronary artery disease (CAD). In a prospective study, we evaluated the effect of 8 pathogens and the aggregate pathogen burden on the risk for future fatal cardiac events among patients with angiographically documented CAD. Methods and Results-In 1018 patients, IgG or IgA antibodies to herpes simplex virus types 1 and 2, cytomegalovirus, Epstein-Barr virus, Haemophilus influenzae, Chlamydia pneumoniae, Mycoplasma pneumoniae, and Helicobacter pylori were determined. Moreover, highly sensitive C-reactive protein was measured. Follow-up information on cardiovascular events was obtained (mean 3.1 years, maximum 4.3 years). Seropositivities to Epstein-Barr virus (P=0.001), H pylori (P=0.002), and herpes simplex virus type 2 (P=0.045) were independently associated with the future risk of cardiovascular death. An increasing number for pathogen burden was significantly predictive of the long-term prognosis (P<0.0001). Infectious burden divided into 0 to 3, 4 or 5, and 6 to 8 seropositivities was associated with an increasing mortality of 3.7%, 7.2%, and 12.6%, respectively. Patients seropositive to >5 pathogens compared with those seropositive to <4 pathogens had a 5.1 (1.4 to 18.3) higher risk of future cardiac death. This result was mainly driven by the pathogen burden of seropositivities to Herpesviridae (P<0.0001). The prognostic impact of total or viral pathogen burden was independent of the C-reactive protein level.
CONCLUSIONS: These results support the hypothesis that the number of infectious pathogens to which an individual has been exposed independently contributes to the long-term prognosis in patients with documented CAD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435333     DOI: 10.1161/hc2601.091703

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  54 in total

Review 1.  Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  The interleukin-6 promoter polymorphism is associated with elevated leukocyte, lymphocyte, and monocyte counts and reduced physical fitness in young healthy smokers.

Authors:  J R Ortlepp; J Metrikat; K Vesper; V Mevissen; F Schmitz; M Albrecht; P Maya-Pelzer; P Hanrath; C Weber; K Zerres; R Hoffmann
Journal:  J Mol Med (Berl)       Date:  2003-08-20       Impact factor: 4.599

Review 3.  Infection and Stroke: an Update on Recent Progress.

Authors:  Eliza C Miller; Mitchell S V Elkind
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

4.  Relationship of five inflammatory gene polymorphisms with morbidity and mortality in 533 patients admitted to an ICU.

Authors:  Jan R Ortlepp; Jürgen Graf; Katharina Vesper; Fabian Schmitz; Vera Mevissen; Sebastian Sucigan; Alexander Kersten; Christian Weber; Uwe Janssens
Journal:  Inflammation       Date:  2005-04       Impact factor: 4.092

Review 5.  Inflammation and ageing.

Authors:  U Müller-Werdan
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

6.  Role of HDL in cholesteryl ester metabolism of lipopolysaccharide-activated P388D1 macrophages.

Authors:  Sabrina Uda; Stefano Spolitu; Fabrizio Angius; Maria Collu; Simonetta Accossu; Sebastiano Banni; Elisabetta Murru; Francesca Sanna; Barbara Batetta
Journal:  J Lipid Res       Date:  2013-08-16       Impact factor: 5.922

7.  Cardiac gene expression and systemic cytokine profile are complementary in a murine model of post-ischemic heart failure.

Authors:  S Lachtermacher; B L B Esporcatte; F Montalvão; P C Costa; D C Rodrigues; L Belem; A Rabischoffisky; H C C Faria Neto; R Vasconcellos; S Iacobas; D A Iacobas; H F R Dohmann; D C Spray; R C S Goldenberg; A C Campos-de-Carvalho
Journal:  Braz J Med Biol Res       Date:  2010-03-06       Impact factor: 2.590

8.  The effect of different strains of Helicobacter pylori on platelet aggregation.

Authors:  Paul A Corcoran; John C Atherton; Steve W Kerrigan; Torkel Wadstrom; Frank E Murray; Richard M Peek; Desmond J Fitzgerald; Dermont M Cox; Michael F Byrne
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

Review 9.  Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.

Authors:  Jacek Budzyński; Marek Koziński; Maria Kłopocka; Julia Maria Kubica; Jacek Kubica
Journal:  Clin Res Cardiol       Date:  2014-05-10       Impact factor: 5.460

10.  Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Moyses Szklo; Jingzhong Ding; Michael Y Tsai; Mary Cushman; Joseph F Polak; João Lima; R Graham Barr; A Richey Sharrett
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2009-10       Impact factor: 2.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.